| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
6,154 |
3,217 |
$266K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
361 |
294 |
$24K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
251 |
250 |
$18K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
479 |
326 |
$16K |
| 99441 |
|
336 |
283 |
$11K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
179 |
126 |
$11K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
142 |
103 |
$5K |
| 87428 |
|
68 |
66 |
$5K |
| 99442 |
|
35 |
35 |
$2K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
640 |
459 |
$2K |
| 99305 |
|
48 |
47 |
$2K |
| 90791 |
Psychiatric diagnostic evaluation |
13 |
13 |
$1K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
30 |
25 |
$530.90 |
| 90688 |
|
13 |
13 |
$39.82 |
| G0008 |
Administration of influenza virus vaccine |
19 |
19 |
$39.69 |